Table 1 Participant’s characteristics according to pathology results
Variables | Non-Atypical (n=32) | Atypical (n=27) | Endometrial Carcinoma (31) | p-value |
|---|---|---|---|---|
Age* | 44.97 ± 6.15 | 40.33 ± 10.33 | 49.29 ± 8.59 | <0.001 |
Body Mass Index | 26.12 ± 5.37 | 28.48 ± 4.79 | 27.57 ± 5.33 | 0.086 |
Parity Episode (Median) | 2 (IQR 0-5) | 2 (IQR 0-3) | 3 (IQR 1-4) | 0.101 |
Abortion Episode (Median) | 0 (IQR 0-1) | 1 (IQR-0-2) | 1 (IQR 0-2) | 0.308 |
Signs, Symptoms and Previous Intervention | ||||
Vaginal Bleeding | 12 (37.5%) | 18 (66.7%) | 15 (48.4%) | 0.081 |
Abdominal Enlargement | 5 (15.6%) | 1 (3.7%) | 13 (41.9%) | 0.001 |
Mennorrhagia# | 6 (18.8%) | 6 (22.2%) | 1 (3.2%) | 0.065 |
Mennometroraghia | 5 (15.6%) | 8 (29.6%) | 6 (19.3%) | 0.404 |
Uterus Bleeding | 20 (62.5%) | 14 (51.8%) | 23 (74.2%) | 0.210 |
Abdominal Pain# | 1 (3.1%) | 2 (7.4%) | 4 (12.9%) | 0.330 |
Hormone Therapy# | 2 (6.2%) | 1 (3.7%) | 2 (6.4%) | 1.000 |
Previous Curretage# | 0 (0%) | 1 (3.7%) | 1 (3.2%) | 0.537 |
Referral Diagnosis | N/A | |||
Abnormal Uterus Bleeding | 16 (50%) | 10 (37.0%) | 1 (3.2%) | |
Endometrial Hyperplasia | 13 (40.1%) | 11 (40.7%) | 4 (12.9%) | |
Ovarian Carcinoma | 1 (3.1%) | 1 (3.7%) | 1 (3.2%) | |
Adenomyosis | 0 (0%) | 1 (3.7%) | 0 (0%) | |
Endometrial Cysts | 0 (0%) | 2 (7.4%) | 0 (0%) | |
Myoma Uteri | 6 (18.8%) | 3 (11.1%) | 2 (6.4%) | |
Cervical Polyp | 0 (0%) | 1 (3.7%) | 0 (0%) | |
Endometrial Polyp | 0 (0%) | 1 (3.7%) | 0 (0%) | |
Endometrial Carcinoma | 0 (0%) | 1 (3.7%) | 24 (77.4%) | |
Cyst Torsion | 0 (0%) | 0 (0%) | 1 (3.2%) | |
β-Catenin | ||||
Intensity | 2.59 ± 0.49 | 2.96 ± 0.19 | 2.77 ± 0.42 | 0.004 |
Percentage | 50.94 ± 22.63 | 68.15 ± 18.82 | 63.87 ± 23.48 | 0.008 |
Percentage Area Level | 2.41 ± 0.49 | 2.78 ± 0.51 | 2.65 ± 0.61 | 0.008 |
H-Score | 138.13 ± 75.79 | 204.07 ± 57.66 | 184.51 ± 68.30 | 0.003 |